In conclusion, we found that the polymorphisms of HSPB1 rs2070804 and HSPA4 rs3088225 were significantly associated with the prognosis in lung cancer patients treated with platinum-based chemotherapy. The gene discussed is HSPB1; the disease is lung cancer.